Clinical Use and Mechanisms of Infliximab Treatment on Inflammatory Bowel Disease: A Recent Update


The pathogenesis and treatment of inflammatory bowel disease (IBD) have been recently advanced, while it is still challenged with high morbidity and poor prognosis. Infliximab, a monoclonal antibody of tumor necrosis factor (TNF), has emerged as an efficient treatment with many clinical benefits such as quick disease activity reduction and IBD patient life… (More)
DOI: 10.1155/2013/581631


1 Figure or Table